File and forget

2Q Stock Wrap-Up

Nobody is going to miss the second quarter. Biotech led a decline that saw the BioCentury 100 Index fall 10%, erasing its 6% gain in the first quarter and putting it down 4% on the year (see "Index Performance"). ...